Sanjar Pharma

Injection manufacturing and pharmaceutical services in India.

About Sanjar Pharma

Sanjar Pharma is a Healthcare company. Injection manufacturing and pharmaceutical services in India. The company has 15 employees. Its Indian entity Sanjar Pharma Llp reported revenue of β‚Ή18.75 Cr. Sanjar Pharma offers products and services including Dry Injections and Liquid Injections. Its focus areas include Pharmaceuticals, Manufacturing, Injection Manufacturing and Sterile Products.

Company details

Sanjar Pharma is recognized as a WHO GMP certified entity that specializes in the production of sterile pharmaceutical items, including injections and eye drops. High-quality standards are maintained to meet domestic and international demands, with a commitment to ethical manufacturing practices. Products are developed for various health segments such as anti-bacterial and CNS drugs, ensuring accessibility. Innovation and compliance with regulations are emphasized, supported by skilled professionals and advanced facilities.

  • Employees 15
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Social LinkedIn X Facebook Instagram
  • Legal Name Sanjar Pharma Llp
  • Date of Incorporation 04 Mar, 2014
  • Jurisdiction Himatnagar, Gujarat, India
Key Metrics
  • Indian entity revenue
    ₹18.75 Cr

    FY 2024 · +10% YoY

  • Indian entity net profit
    ₹3.96 Cr

    FY 2024 · 21% margin

  • Indian entity EBITDA
    ₹4.74 Cr

    FY 2024 · 25% margin

  • Employee Count
    15

Products & Services of Sanjar Pharma

Sanjar Pharma offers a comprehensive portfolio of products and services, including Dry Injections and Liquid Injections.

Dry Injections
Pharmaceutical Products

Dry injections are provided for rapid medical solutions, with precise dosage ensured for various needs.

Liquid Injections
Pharmaceutical Products

Liquid injections are formulated for fast absorption and superior medical outcomes in treatment applications.

Board of directors of Sanjar Pharma Llp (Sanjar Pharma)

Sanjar Pharma Llp is the primary company behind Sanjar Pharma. The board of Sanjar Pharma Llp currently have 2 directors; the longest-serving is Mohmadazaz Mohmadyunus Mukdiwala, appointed in 2014. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mohmadazaz Mohmadyunus Mukdiwala
DIN 06728067
Designated Partner04 Mar 201412 yrs 7 moSanjar Pharma Llp
Mohmadmoin Khalilahmed Modasiya
DIN 06728079
Designated Partner04 Mar 201412 yrs 7 moSanjar Pharma Llp

Financials of Sanjar Pharma

Figures of Sanjar Pharma Llp, the primary company behind Sanjar Pharma, for FY 2024. Revenue was ₹18.75 Cr (+10% year on year). Net profit was ₹3.96 Cr (21% margin). EBITDA was ₹4.74 Cr (25% margin). Revenue has grown at a compounded annual rate of +10% over three years and +16% over five years.

  • ₹18.75 CrRevenue · FY 2024 · +10% YoY
  • ₹3.96 CrNet profit · 21% margin
  • ₹4.74 CrEBITDA · 25% margin
  • 15Employees (provident fund records)
  • +10%Revenue CAGR, 3 years
  • +16%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sanjar Pharma Llp are on its company page.

Premium access

Detailed financial statements for Sanjar Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sanjar Pharma

Sanjar Pharma has 15 employees.

The primary company behind Sanjar Pharma, Sanjar Pharma Llp, reported revenue of β‚Ή18.75 Cr for FY 2024, up 10% year on year.

Sanjar Pharma is recognized as a WHO GMP certified entity that specializes in the production of sterile pharmaceutical items, including injections and eye drops. High-quality standards are maintained to meet domestic and international demands, with a commitment to ethical manufacturing practices. Products are developed for various health segments such as anti-bacterial and CNS drugs, ensuring accessibility. Innovation and compliance with regulations are emphasized, supported by skilled professionals and advanced facilities.

Sanjar Pharma offers Dry Injections and Liquid Injections.

Sanjar Pharma operates through Sanjar Pharma Llp.

The legal entities of Sanjar Pharma currently have 2 directors, including Mohmadazaz Mohmadyunus Mukdiwala, Mohmadmoin Khalilahmed Modasiya.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available